Connection

David Perry to Molecular Targeted Therapy

This is a "connection" page, showing publications David Perry has written about Molecular Targeted Therapy.
Connection Strength

0.021
  1. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. Br J Pharmacol. 2011 Jun; 163(4):694-712.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.